Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Spectrophotometer

By Drug Discovery Trends Editor | March 23, 2010

gehealthcareGE Healthcare launches the NanoVue Plus spectrophotometer for the rapid and accurate quantification of nucleic acids & protein samples.  It can measure volumes as low as 0.5?l due to the “drop and measure” sample plate and does not require cuvettes or capillaries.

The NanoVue Plus features the latest sample plate for the NanoVue spectrophotometers. This plate has enhanced compatibility with the wide range of chemicals and sample types used in today’s busy laboratories.  The plate is hydrophobic which enables easy sample recovery and cleaning, helping to prevent carry-over between measurements.

The built-in software provides a user-friendly interface, with convenient drop-down lists that include methods for measuring common fluors including the full CyDye™ range. Researchers can also choose from a wide range of storage methods and data output options, such as integrated printer option, Print-Via-Computer software, optional wireless connectivity and new SD card accessory

Recalibration of NanoVue Plus can be done easily in the lab by the scientists themselves.

Other features include:

•  Stand-alone instrument with small foot-print and without PC- freeing up valuable bench space
•  Wide wavelength range from 200-1100nm – providing the scope for a great range of samples
•  90 user-defined methods can be stored with password protection – ideal for multi-user labs

The new sample plate, SD card reader and latest software can be fitted onto existing NanoVue instruments.

GE Healthcare


Filed Under: Drug Discovery

 

Related Articles Read More >

Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE